Sat, Sep 20, 2014, 4:35 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

MiMedx Group, Inc. Message Board

  • earth457 earth457 Dec 4, 2013 12:35 PM Flag

    Jason Napodano

    He expressed concerns about the profit margins here in 2015, but he doesn't know for certain the exact reimbursement rate, or if it will change between now and 2015.

    Furthermore, I'd rather trade off a little in profit margin for higher revenues since companies like MiMedx are usually acquired as a multiple of revenues, and not a multiple of gross margins.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • He works for Zacks...enough said...not exactly first rate analysis from that group...

      Sentiment: Strong Buy

    • Jason should explain. For 2014, Products above $32 sq cm fall into the high cost category. If CMS receives 2-3 years of Expifix pricing data, it should fall into the high cost category as stated by management. So what exactly is Jason's argument? That Epifix will not appear in the high cost category? A few of the goals of CMS is to minimize waste and promote competition (price) among the products . Placing Epifix in the high category should help achieve this. Does he know something that wasn't in the CMS ruling?

      • 1 Reply to strut1702
      • I'm not certain what his beef is about. We are going to give up some profit margin on anything sold by Medtronic, but I hardly think Pete Petit will change MiMedx into the Costco of the tissue industry as some people have implied.

        I'm still all for increasing revenues, even if it means giving up a little of the profit margin to do it.

        I was most impressed by the statement in the recent press release that said MiMedx only needed to penetrate 2.5% of the market to achieve 2014 sales forecasts. In my opinion, the company will blow that away.

7.29-0.11(-1.49%)Sep 19 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.